ArticleCell & bioscience2022

Discovery and mechanism studies of a novel ATG4B inhibitor Ebselen by drug repurposing and its anti-colorectal cancer effects in mice.

Huazhong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.